|
Report Date : |
24.05.2014 |
IDENTIFICATION DETAILS
|
Name : |
COPERMED COMERCIAL IMPORTADORA LTDA |
|
|
|
|
Registered Office : |
Rua dr. Murilo carvalho coutinho,90 - fatima iii 37500-000 - pouso alegre/mg |
|
|
|
|
Country : |
Brazil |
|
|
|
|
Financials (as on) : |
31.12.2012 |
|
|
|
|
Date of Incorporation : |
09.07.2007 |
|
|
|
|
Legal Form : |
Limited Liability Company |
|
|
|
|
Line of Business : |
Wholesale of pharmaceuticals |
|
|
|
|
No. of Employees : |
14 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
Payment Behaviour : |
No complaints |
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31, 2014
|
Country Name |
Previous Rating (31.12.2013) |
Current Rating (31.03.2014) |
|
Brazil |
A2 |
A2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low Risk |
A2 |
|
Moderately Low Risk |
B1 |
|
Moderate Risk |
B2 |
|
Moderately High Risk |
C1 |
|
High Risk |
C2 |
|
Very High Risk |
D |
BRAZIL - ECONOMIC OVERVIEW
Characterized by large and well-developed agricultural, mining, manufacturing, and service sectors, Brazil's economy outweighs that of all other South American countries, and Brazil is expanding its presence in world markets. Since 2003, Brazil has steadily improved its macroeconomic stability, building up foreign reserves, and reducing its debt profile by shifting its debt burden toward real denominated and domestically held instruments. In 2008, Brazil became a net external creditor and two ratings agencies awarded investment grade status to its debt. After strong growth in 2007 and 2008, the onset of the global financial crisis hit Brazil in 2008. Brazil experienced two quarters of recession, as global demand for Brazil's commodity-based exports dwindled and external credit dried up. However, Brazil was one of the first emerging markets to begin a recovery. In 2010, consumer and investor confidence revived and GDP growth reached 7.5%, the highest growth rate in the past 25 years. Rising inflation led the authorities to take measures to cool the economy; these actions and the deteriorating international economic situation slowed growth in 2011-13. Unemployment is at historic lows and Brazil's traditionally high level of income inequality has declined for each of the last 14 years. Brazil's historically high interest rates have made it an attractive destination for foreign investors. Large capital inflows over the past several years have contributed to the appreciation of the currency, hurting the competitiveness of Brazilian manufacturing and leading the government to intervene in foreign exchange markets and raise taxes on some foreign capital inflows. President Dilma ROUSSEFF has retained the previous administration's commitment to inflation targeting by the central bank, a floating exchange rate, and fiscal restraint
|
Source
: CIA |
COPERMED COMERCIAL
IMPORTADORA LTDA
|
MAIN ADDRESS: |
RUA DR. MURILO CARVALHO COUTINHO,90 - FATIMA III |
|
ZIP CODE/CITY: |
37500-000 - POUSO ALEGRE/MG |
|
|
|
|
PHONE: |
35 3421-1124 |
|
FAX: |
35 3421-1124 |
|
E-MAIL: |
copermed@bol.com.br |
|
WEB SITE: |
www.copermed.com |
|
BRANCHES: |
|
|
|
|
|
ADDRESS: |
RUA IRMÃ ELIZABETH DE BARROS COBRA,180 - NOVA POUSO ALEGRE |
|
ZIP CODE/CITY: |
37550-000 POUSO ALEGRE/MG |
|
PHONE: |
35 3422-9744 |
|
FAX: |
35 3422-9744 |
|
MAIN ACTIVITIES: |
|
WHOLESALE OF PHARMACEUTICALS. |
|
LEGAL FORM: |
LIMITED LIABILITY COMPANY |
|
|
|
|
INCORPORATION DATE: |
09/07/2007 |
|
REGISTER DATE: |
09/07/2007 |
|
BALANCE SHEET FILING DATE: |
31/12 |
|
TAX CONTRIBUTOR NUMBER(CNPJ): |
09.029.404/0001-82 |
|
STATE REGISTER: |
001.042.00000-97 |
|
|
|
|
SHARE CAPITAL: |
R$ 12.600,00 |
|
BOARD OF DIRECTORS: |
|
|
|
|
|
BRUNO ALEXANDRE DEMORI |
MANAGING PARTNER |
|
THE MANAGING PARTNER IS AUTHORIZED TO SIGN ON BEHALF OF THE COMPANY. |
|
SHAREHOLDERS / PARTNERS: |
|
|
|
|
|
ANGELO EURICO DEMORI (DECEASED) |
99% |
|
BRUNO ALEXANDRE DEMORI |
1% |
|
AFFILIATES / SUBSIDIARIES: |
|
|
|
|
|
NO SHARE INTERESTS IN OTHER COMPANIES WERE NOTED |
|
|
THE SUBJECT WAS ESTABLISHED ON JULY 9, 2007 AS COPREMED COMERCIO DE PERFUMARIA E MEDICAMENTOS LTDA. TO BE ENGAGED IN THE SAID LINE OF BUSINESS. LATER IT ADOPTED THE ABOVE MENTIONED NAME AND UP TO DATE IT IS STILL OPERATING WITHIN THE GENERAL SCENE REPORTED HEREIN. BUSINESS ADDRESS HAS CHANGED FROM (RODOVIA JK, KM (BR 459), 111 S/Nº - BAIRRO DOS CHAVES, POUSO ALEGRE/MG) TO THE PRESENT REGISTERED ONE. TRADE NAME: "COPERMED" PARTNERS: ANGELO EURICO DEMORI: REPRESENTED BY BRUNO ALEXANDRE DEMORI BRUNO ALEXANDRE DEMORI: BRAZILIAN, SINGLE, ENTREPRENEUR, HOLDER OF DOCUMENTS CPF 376.360.938-55 AND RG 44.553.570-2, SSP/SP, RESIDENTIAL ADDRESS AT RODOVIA J.K. 111, S/Nº. BAIRRO DOS CHAVES, ZIP CODE 37550-000, POUSO ALEGRE/MG. FURTHER DETAILS ABOUT THE SUBJECT'S HISTORY ARE SO FAR NOT KNOWN. |
|
PUBLIC INFORMATION: |
|
NO DETRIMENTAL FILES WERE FOUND. |
|
THE SUBJECT FILES THE ACCOUNTS THROUGH AN ACCOUNTANCY PROCEEDING NAMED "LUCRO PRESUMIDO" (PRESUMED PROFIT) WHICH EXEMPTS IT OF BUILDING UP BALANCE SHEET OR ANY OTHER BOOKING PROCEEDINGS WHICH ARE USUAL FOR COMPANIES WHICH FILE ACCOUNTS THROUGH THE ACCOUNTANCY PROCEEDING NAMED "LUCRO REAL" (REAL PROFIT). |
|
GENERAL BALANCE SHEETS AS OF 31/12/2012, 31/12/2011 AND 31/12/2010. |
|
( FIGURES ARE IN REAIS ). |
|
ASSETS |
|
|
|
|
CURRENT: |
31/12/2012 |
31/12/2011 |
31/12/2010 |
|
|
|
|
|
|
CASH AND CASH EQUIVALENTS |
59.595,48 |
148.535,47 |
131.636,77 |
|
CLIENTS |
876.281,64 |
180.432,59 |
94.623,74 |
|
ADVANCE TO SUPPLIERS |
46.022,54 |
144.960,13 |
60.760,13 |
|
ADVANCES |
25.512,74 |
59.781,00 |
|
|
RECOVERABLE TAXES |
304.594,08 |
25.987,09 |
11.518,92 |
|
INVENTORY |
1.650.059,15 |
368.452,58 |
423.067,57 |
|
ADVANCE TO EMPLOYEES |
43.700,00 |
|
|
|
|
---------------- |
---------------- |
---------------- |
|
TOTAL CURRENT ASSETS |
3.005.765,63 |
928.148,86 |
721.607,13 |
|
LONG-TERM RECEIVABLES: |
|
|
|
|
|
|
|
|
|
ACCOUNTS RECEIVABLES |
495.193,85 |
501.405,59 |
|
|
JUDICIAL DEPOSITS |
35.433,01 |
|
|
|
OTHER CREDITS |
242.616,62 |
|
|
|
|
---------------- |
---------------- |
---------------- |
|
TOTAL LONG-TERM RECEIVABLES |
773.243,48 |
501.405,59 |
|
|
FIXED ASSETS: |
|
|
|
|
|
|
|
|
|
FIXED ASSETS |
460.349,64 |
267.979,04 |
109.127,67 |
|
|
---------------- |
---------------- |
---------------- |
|
TOTAL FIXED ASSETS |
460.349,64 |
267.979,04 |
109.127,67 |
|
|
================ |
================ |
================ |
|
TOTAL ASSETS |
4.239.358,75 |
1.697.533,49 |
830.734,80 |
|
LIABILITIES: |
|
|
|
|
CURRENT: |
31/12/2012 |
31/12/2011 |
31/12/2010 |
|
|
|
|
|
|
LABOR OBLIGATIONS |
104.905,54 |
96.920,13 |
58.080,10 |
|
TRIBUTARY OBLIGATIONS |
240.574,76 |
207.314,03 |
99.996,25 |
|
FINANCING |
|
12.196,32 |
41.666,67 |
|
SUPPLIERS |
2.378.971,78 |
1.037.499,86 |
516.313,25 |
|
OTHER |
101,39 |
11.443,72 |
|
|
|
---------------- |
---------------- |
---------------- |
|
TOTAL CURRENT LIABILITIES |
2.724.553,47 |
1.365.374,06 |
716.056,27 |
|
LONG TERM LIABILITIES: |
|
|
|
|
|
|
|
|
|
LOANS AND FINANCING |
138.949,38 |
27.865,71 |
52.306,40 |
|
|
---------------- |
---------------- |
---------------- |
|
TOTAL LONG TERM LIABILITIES |
138.949,38 |
27.865,71 |
52.306,40 |
|
NET EQUITY: |
|
|
|
|
|
|
|
|
|
SHARE CAPITAL |
12.600,00 |
12.600,00 |
12.600,00 |
|
ACCRUED PROFIT (LOSS) |
1.363.255,90 |
291.693,72 |
49.772,13 |
|
|
---------------- |
---------------- |
---------------- |
|
TOTAL NET EQUITY |
1.375.855,90 |
304.293,72 |
62.372,13 |
|
|
================ |
================ |
================ |
|
TOTAL LIABILITIES |
4.239.358,75 |
1.697.533,49 |
830.734,80 |
|
PROFIT AND LOSS ACCOUNTS AS OF 31/12/2012, 31/12/2011 AND 31/12/2010. |
|
( FIGURES ARE IN REAIS ). |
|
|
31/12/2012 |
31/12/2011 |
31/12/2010 |
|
|
|
|
|
|
GROSS SALES |
9.655.329,15 |
3.860.020,75 |
2.347.480,15 |
|
(-) TAXES ON SALES |
980.734,18 |
396.309,96 |
234.388,71 |
|
|
---------------- |
---------------- |
---------------- |
|
NET SALES |
8.674.594,97 |
3.463.710,79 |
2.113.091,44 |
|
(-) COST OF SOLD GOODS |
4.798.505,38 |
2.077.185,32 |
1.022.365,83 |
|
|
---------------- |
---------------- |
---------------- |
|
GROSS PROFIT |
3.876.089,59 |
1.386.525,47 |
1.090.725,61 |
|
OPERATING REVENUE (EXPENSE) |
-2.451.296,88 |
-986.278,32 |
-703.367,45 |
|
FINANCIAL REVENUE(EXPENSE) |
-86.844,09 |
-60.697,34 |
-64.076,21 |
|
|
---------------- |
---------------- |
---------------- |
|
OPERATIONAL PROFIT (LOSS) |
1.337.948,62 |
339.549,81 |
323.281,95 |
|
NON-OPERATING RESULT |
-476,71 |
|
|
|
CONTRIBUTION/INCOME TAX |
-265.909,73 |
-97.628,22 |
-52.811,19 |
|
|
---------------- |
---------------- |
---------------- |
|
NET PROFIT (LOSS) |
1.071.562,18 |
241.921,59 |
270.470,76 |
|
MONTHLY SALES |
|||
|
|
2013 |
|
|
|
|
--------------------- |
|
|
|
JANUARY |
R$ 951.172,94 |
|
|
|
FEBRUARY |
R$ 873.381,27 |
|
|
|
MARCH |
R$ 1.286.109,62 |
|
|
|
APRIL |
R$ 1.430.140,11 |
|
|
|
MAY |
R$ 1.486.209,80 |
|
|
|
JUNE |
R$ 1.822.906,75 |
|
|
|
JULY |
R$ 1.721.959,47 |
|
|
|
AUGUST |
R$ 1.857.663,35 |
|
|
|
SEPTEMBER |
R$ 1.141.358,03 |
|
|
|
OCTOBER |
R$ 1.768.799,81 |
|
|
|
NOVEMBER |
R$ 2.188.865,75 |
|
|
|
DECEMBER |
R$ 1.414.005,28 |
|
|
|
TOTAL |
R$ 17.942.572,18 |
|
|
|
RATIOS: |
31/12/2012 |
31/12/2011 |
31/12/2010 |
|
QUICK RATIO |
,50 |
|
,41 |
|
,42 |
|
|
CURRENT RATIO |
1,10 |
|
,68 |
|
1,01 |
|
|
ACCOUNTS RECEIVABLE TURNOVER |
9,90 |
TIMES |
19,20 |
TIMES |
22,33 |
TIMES |
|
DAYS' SALES IN RECEIVABLES |
36,37 |
DAYS |
18,75 |
DAYS |
16,12 |
DAYS |
|
INVENTORY TURNOVER |
2,91 |
TIMES |
5,64 |
TIMES |
2,42 |
TIMES |
|
ACCOUNTS PAYABLE PERIOD |
178,48 |
DAYS |
179,81 |
DAYS |
181,81 |
DAYS |
|
RETURN ON ASSETS |
2,05 |
TIMES |
2,04 |
TIMES |
2,54 |
TIMES |
|
SALES TURNOVER ON NET EQUITY |
6,30 |
TIMES |
11,38 |
TIMES |
33,88 |
TIMES |
|
NET WORTH TIE-UP |
,33 |
|
,88 |
|
1,75 |
|
|
INDEBTEDNESS |
2,08 |
|
4,58 |
|
12,32 |
|
|
EQUITY RATIO |
32,45 |
% |
17,93 |
% |
7,51 |
% |
|
WORKING CAPITAL RATIO |
10,32 |
% |
-32,02 |
% |
,78 |
% |
|
GENERAL SOLVENCY |
1,48 |
|
1,22 |
|
1,08 |
|
|
RETURN ON NET EQUITY |
77,88 |
% |
79,50 |
% |
433,64 |
% |
|
RETURN ON SALES (PROFIT MARGIN) |
12,35 |
% |
6,98 |
% |
12,80 |
% |
|
GROSS PROFIT MARGIN |
44,68 |
% |
40,03 |
% |
51,62 |
% |
|
OPERATIONAL RESULT |
15,42 |
% |
9,80 |
% |
15,30 |
% |
|
SALES TURNOVER ON LIABILITIES |
3,18 |
TIMES |
2,54 |
TIMES |
2,95 |
TIMES |
|
FOREIGN CURRENCY ON ASSETS |
|
|
|
|
|
|
|
FOREIGN CURRENCY ON LIABILITIES |
|
|
|
|
|
|
|
EXCHANGE RATE: |
|
|
US$ 1,00 = R$ 2,33 |
- OFFICIAL RATE ON 25/02/2014 |
|
US$ 1,00 = R$ 2,04 |
- OFFICIAL RATE ON 31/12/2012 |
|
US$ 1,00 = R$ 1,87 |
- OFFICIAL RATE ON 31/12/2011 |
|
US$ 1,00 = R$ 1,66 |
- OFFICIAL RATE ON 31/12/2010 |
|
COMMENTS ON THE
FINANCIAL INFORMATION: |
|
FOLLOWS ATTACHED WORKSHEET WITH MAIN FINANCIAL RATIOS. THE FIGURES AVAILABLE SHOW A SATISFACTORY FINANCIAL STANDING. THE LEVEL OF INDEBTEDNESS IS HIGH BUT IT HAS GOOD CURRENT RATIOS AND POSITIVE WORKING CAPITAL, CONSIDERED SUFFICIENT TO COVER THE SHORT TERM DEBTS. IT ALSO SHOWS GROWING SALES AND PROFITABILITY. REMARKS: THE INCREASE IN THE SALES VOLUME WAS ATTRIBUTABLE TO THE INCREASE OF THE DEMAND. ACCORDING TO THE RULES OF THE ACCOUNTANCY PROCEEDING FOLLOWED BY THE SUBJECT, IT COLLECTS THE TAXES, WHICH ARE DUE OVER THE GROSS SALES AMOUNT. THE TAXES SHOULD BE COLLECTED EITHER WITH PROFIT OR LOSS AT THE END OF THE FISCAL YEAR. REGARDING THE RULES OF THE ABOVE SAID PROCEEDING IT MAY BE POSSIBLE TO STATE THAT COMPANIES WHICH FILE ACCOUNTS THROUGH THIS PROCEEDING ARE PROFITABLE COMPANIES. IT IS STATED BECAUSE THE MAIN DIFFERENCE OF THE PROCEEDING NAMED "LUCRO REAL" AND THE ONE NAMED "LUCRO PRESUMIDO" IS THAT IN THE FIRST THE COMPANY ONLY PAYS INCOME TAX WHEN IT HAS PROFIT AT THE END OF THE FISCAL YEAR, WHILE IN THE LAST THE COMPANY PAYS INCOME TAX REGARDLESS IT HAS PROFIT OR LOSS. THEREFORE, IF ANY COMPANY WHICH ADOPTS THE "PRESUMED PROFIT" PROCEEDING WAS NOT PROFITABLE IT WOULD BE A BETTER OPTION TO FILE ACCOUNTS THROUGH THE "LUCRO REAL" PROCEEDING BECAUSE IN THIS PROCEEDING TAXES ARE DUE ONLY WHEN PROFITABLE RESULTS ARE MET. IN CASE OF LOSSES NO INCOME TAX IS DUE. |
|
REAL ESTATE: |
OWNED PREMISES ARE VALUED AT R$ 150.500,00
THE PARTNERS OWN REAL ESTATE VALUED AT R$ 350.000,00
|
VEHICLES: |
OWNED VEHICLES ARE VALUED AT R$ 324.465,00
|
MACHINES: |
OWNED MACHINES AND EQUIPMENTS ARE VALUED AT R$ 56.827,90
|
INSURANCE COMPANY: |
BRADESCO SEGUROS |
|
COVERAGE: |
INVENTORY (ROBBERY / FIRE) |
|
VALUE: |
R$ 500.000,00 |
|
|
BRANCH/PHONE: |
|
|
BANCO SANTANDER S/A |
3255 / 35 3429-7100 |
|
|
BANCO ITAÚ S/A |
7347 |
POUSO ALEGRE/MG |
|
BANCO DO BRASIL S/A |
0368-9 / 35 3449-4600 |
|
|
REMARKS: IN BRAZIL THE BANKS ARE PROHIBITED BY LAW TO PROVIDE INFORMATION OR ANY KIND OF COMMENTS ABOUT THEIR CLIENTS. DUE TO THIS LAW PROHIBITION WE ARE UNABLE TO PROVIDE ANY BANKING DETAILS. ACCORDING TO THE CENTRAL BANK OF BRAZIL OFFICIAL REPORT, THE COMPANY HAS RETURNED CHECKS UP TO DATE. (IN THE TERMS OF "CIRCULAR 1682 BRAZILIAN CENTRAL BANK"). |
|
WHOLESALE OF PHARMACEUTICALS. |
|
IMPORT AND
EXPORT: |
IMPORTS FROM:
|
INDIA AND EUROPE. |
EXPORTS TO:
|
ARGENTINA, URUGUAY, PARAGUAY AND CHILE. |
|
MAIN CLIENTS: |
|
|
|
|
|
|
|
DOMESTIC CLIENTS: |
|
PHONE: |
|
ADRIVAN |
|
11 4043-0411 |
|
BELFAR INDUSTRIA FARMACEUTICA |
|
31 3492-1100 |
|
CIMED INUSTRIA MEDICAMENTOS LTDA |
|
11 3544-7200 |
|
FAGRON DO BRASIL FARMACEUTICA LTDA |
|
11 5033-3700 |
|
HYPERMARCAS S/A |
|
62 3310-2500 |
|
HYPOFARMA INST. HYPODERMA |
|
31 3626-9019 |
|
LABORATORIO TEUTO |
|
62 3310-2088 |
|
MEDQUIMICA |
|
32 3222-1433 |
|
NEO QUIMICA |
|
62 3310-2400 |
|
NOVAFARMA INDUSTRIA FARMACEUTIVA |
|
62 3310-8200 |
|
ROYTON INDUSTRIA FARMACEUTICA |
|
11 2107-9008 |
|
VALDEQUIMICA PRODUTOS QUIMICOS |
|
11 3721-6407 |
|
STAFF: |
|
|
|
THE COMPANY HAS: 14 EMPLOYEE(S) |
|
THE SUBJECT WAS ESTABLISHED IN 2007. SO FAR IT HAS A CLEAR TRADE HISTORY AND NORMAL PAYMENT BEHAVIOR. THE COMPANY HAS TRADE RELATIONS WITH SOME LOCAL SUPPLIERS BUT UP TO DATE ONLY SMALL PAYMENTS WERE REPORTED AND THE SUBJECT IS NOT SAID TO BE USER OF TRADE CREDIT FACILITIES. |
|
MAIN SUPPLIERS: |
|
|
|
|
|
|
|
DOMESTIC SUPPLIERS: |
|
|
|
LABORIS FARMACEUTICA LTDA |
|
|
|
OURO FINO SAUDE ANIMAL LTDA |
|
16 3518-2326 |
|
PAULINERIS TRANSPORTES E ENCOMENDAS LTDA |
|
35 3422-8935 |
|
PHARMASAIS COM. DIS. ESP.FARMACEUTICA LTDA |
|
11 3806-1760 |
|
TRANSPALLET TRANSPORTES E LOGISTICA LTDA |
|
11 2445-5515 |
|
FOREIGN SUPPLIERS: |
COUNTRY: |
|
|
DP PHARM CHEM |
GERMANY |
|
|
INDOCO REMEDIES |
INDIA |
|
|
JIANGSU GUOTAI INTERN. GROUP |
CHINA |
|
|
LACTOSE INDIA LTD |
INDIA |
|
|
SHAANXI TIANRUN PHYTOCHEMICAL CO |
|
|
|
SINOCHEM LIAONING CORPORATION |
CHINA |
|
|
SURYA PHARMACEUTICALS |
INDIA |
|
|
TECNHO DRUGS POLYDUGCOS |
|
|
|
VUAB FARMA AS |
|
|
|
PAYMENT HISTORY: |
|
2 SUPPLIERS REPORTED PAYMENTS: |
|
TOTAL AMOUNT: R$ 13.762,00 |
|
|
|
AMOUNT OF INVOICES PAID: 5 |
|
TOTAL OF PROMPT PAYMENTS: 100% |
|
HIGHEST INVOICE: R$ 6.021,00 |
|
HIGHEST CREDIT: R$ 6.021,00 |
|
FINAL OPINION: |
|
BASED ON THE GENERAL INFORMATION AVAILABLE IT IS BELIEVED THAT GOOD TRADE RELATIONS MAY BE ESTABLISHED. CREDIT FACILITIES MAY BE EXTENDED WITHIN TERMS AND AMOUNTS ADEQUATE TO THE COMPANY'S FINANCIAL STRENGTH. |
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.58.48 |
|
|
1 |
Rs.98.67 |
|
Euro |
1 |
Rs.79.80 |
INFORMATION DETAILS
|
Report Prepared
by : |
PDT |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall
operation is considered normal. Capable to meet normal commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess
SC’s credit risk and to set the amount of credit to be extended. It is
calculated from a composite of weighted scores obtained from each of the major
sections of this report. The assessed factors and their relative weights (as
indicated through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.